Financial News Directly From The Source Latest Reports Latest Research

Solid results: Revenue, adjusted EBIT and free cash flow increase

SAF-HOLLAND with a solid start to fiscal year 2024: Adjusted EBIT margin significantly improved to 9.6 per cent in the first quarter – full-year guidance confirmed

Patrimonium Private Equity and Wille Finance acquire majority stake in :em engineering methods AG

DocMorris AG: Daniel Wüest becomes new CFO at DocMorris

Vitesco Technologies starts with solid quarterly results into fiscal year 2024

STEMMER IMAGING: expectedly challenging market environment in Q1 2024 – positive signals in order intake – Full-year forecast confirmed

EDAG has appointed Harald Keller as CEO

Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives

SMA Group kicks off 2024 fiscal year with sales and profitability in line with expectations

Stabilus SE closes Q2 FY2024 with a slight increase in revenue

KNAUS TABBERT SUCCESSFULLY STARTS THE 2024 FINANCIAL YEAR – STRONG INCREASE IN EARNINGS IN THE FIRST QUARTER OF 2024

SYNLAB delivers strong performance in Q1 2024

Change to Group Management

Knorr-Bremse Increases Profitability Significantly at the Beginning of the Year

Aurubis achieves another strong result in first half of 2023/24

ALSO announces areas of responsibility of the new Group Management: Clear sales focus for further growth

MPC Capital with strong first quarter: Key financial figures underline highly profitable business model

Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects

EDAG Engineering Group AG: Harald Keller appointed CEO as of July 01, 2024

STRABAG expands service portfolio in technical facility management with acquisition of parts of VAMED

STRABAG SE: STRABAG planning to acquire parts of VAMED Group together with PORR

DEUTZ AG: Timo Krutoff, buy

Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024

Biotest AG: Annual General Meeting approves dividend distribution

Brockhaus Technologies AG: Significant increase in revenue by 18.5% to €39.6 million and in adjusted EBITDA by 18.0% to €11.4 million (28.7% margin) in Q1 2024 – forecast 2024 unchanged

SynBiotic SE schließt Einbringungsvertrag über den Erwerb aller Anteile an der WEECO Pharma GmbH, Hildesheim ab

Medacta announces the results of today’s Annual General Meeting

AS PlusPlus Capital Progresses in Restructuring Process – Application for Approval of Restructuring Plan Submitted to Court Following Investor Voting